|
Post by seanismorris on Nov 27, 2018 21:55:54 GMT -5
Not to be a Debbie Downer, but I haven’t seen Board Members actually do much...
Sure, they determine executive pay and occasionally show those executives the door (frequently with an undeserved “golden parachute”) but they don’t provide the great insight that investors seem to expect.
A Board member is often where the company founder gets stashed when he’s no longer wanted, while still collecting a salary.
In this case, MannKind is probably just checking the box of a public company requirement.
When you remove Michael Castagna’s age from the average age of our Board of Directers, most of us can expect to be pushing up daisies before reaching that average age.
|
|
|
Post by longliner on Nov 27, 2018 22:03:15 GMT -5
I see the addition to our BOD of a professional, that was CEO of a Canadien company, that produced inhaled Pharmaceutical products, as a positive for our company.
|
|
|
Post by mnkdfann on Nov 27, 2018 22:38:44 GMT -5
|
|
|
Post by longliner on Nov 27, 2018 23:29:59 GMT -5
You little bugger!
|
|
|
Post by mnkdfann on Nov 27, 2018 23:36:18 GMT -5
You little bugger! LOL. Practically nothing to do with Mannkind is ever straightforward!
|
|
|
Post by longliner on Nov 27, 2018 23:42:36 GMT -5
Agree
|
|
|
Post by #NoMoreNeedles on Dec 26, 2018 13:30:42 GMT -5
Really strange that they hired her with the bankruptcy history. This just doesn't add reassurance to the whole company development history.
|
|
|
Post by cedafuntennis on Dec 26, 2018 15:29:30 GMT -5
I would see as a positive once I see some, any, results directly or indirectly linked to the appointment. So far quiet as the snow flakes on this screen from most if not all of the BOD...
|
|